Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | CTSS | P25774 | 3/20 | 0.47 |
| ▸ | CTSK | P43235 | 3/20 | 0.47 |
| ▸ | CTSL | P07711 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | RXRA | P19793 | 1/20 | 0.45 |
| ▸ | RXRB | P28702 | 1/20 | 0.45 |
| ▸ | RXRG | P48443 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 1/20 | 0.45 |
| ▸ | DRD4 | P21917 | 1/20 | 0.45 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.45 |
| ▸ | AOC2 | O75106 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15330864 | 0.84 | HTR1B (0.51) | CTSSCTSKCTSLALDH1A1KDM4E | |
| SCHEMBL1988795 | 0.81 | ALDH1A1 (0.48) | NPSR1ALDH1A1GLACYP1A2KDM4E | |
| SCHEMBL2562138 | 0.80 | HPGD (0.50) | NPSR1ALDH1A1CYP1A2KDM4ENPC1 | |
| SCHEMBL31219294 | 0.79 | ALDH1A1 (0.59) | NPSR1ALDH1A1GLACYP1A2KDM4E | |
| SCHEMBL995137 | 0.79 | ALDH1A1 (0.59) | NPSR1ALDH1A1GLACYP1A2KDM4E | |
| SCHEMBL3946342 | 0.79 | L3MBTL1 (0.53) | NPSR1CTSSCTSKCTSLALDH1A1 | |
| SCHEMBL514581 | 0.79 | CA1 (0.54) | CTSSCTSKCTSLCYP1A2RXRA | |
| SCHEMBL2090885 | 0.78 | ALDH1A1 (0.53) | NPSR1ALDH1A1GLACYP1A2KDM4E | |
| SCHEMBL27397678 | 0.78 | ALDH1A1 (0.46) | NPSR1ALDH1A1GLACYP1A2KDM4E | |
| Hydrogen Sulfide SCHEMBL28263437 | 0.78 | ALDH1A1 (0.58) | NPSR1ALDH1A1GLACYP1A2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2594626-A1 | Use of oxyacetaldehyde as lily of the valley fragrance | Symrise AG (DE) | 2013-05-22 | — | — | EP | claimed |
| US-7018978-B2 | Fragrance pro-accords and aldehyde and ketone fragrance libraries | PROCTER & GAMBLE COMPANY (US) | 2006-03-28 | — | — | US | claimed |
| US-12527779-B2 | Prostaglandin E2 (PGE2) EP4 receptor antagonists | DOMAIN THERAPEUTICS (FR) | 2026-01-20 | — | — | US | disclosed |
| EP-4486860-A1 | BLOOMING COEFFICIENT | Henkel AG & Co. KGaA (DE) | 2025-01-08 | — | — | EP | disclosed |
| EP-4486861-A1 | MULTILAYER SYSTEM COMPRISING COMPOSITIONS HAVING SPECIFIC PERFUME COMPOSITIONS | Henkel AG & Co. KGaA (DE) | 2025-01-08 | — | — | EP | disclosed |
| EP-4351774-A1 | COMPOSITIONS CONTAINING COLOUR-NEUTRAL DEGRADABLE MICROCAPSULES | Henkel AG & Co. KGaA (DE) | 2024-04-17 | — | — | EP | disclosed |
| WO-2024056507-A1 | CURABLE SILICONE COMPOSITIONS CONTAINING ADDITIVES | HENKEL AG & CO. KGAA (DE) | 2024-03-21 | — | — | WO | disclosed |
| EP-4038052-B1 | PROSTAGLANDIN E2 (PGE2) EP4 RECEPTOR ANTAGONISTS | DOMAIN THERAPEUTICS (FR) | 2024-02-07 | — | — | EP | disclosed |
| WO-2023165897-A1 | MULTILAYER SYSTEM COMPRISING COMPOSITIONS HAVING SPECIFIC PERFUME COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023165910-A1 | BLOOMING COEFFICIENT | HENKEL AG & CO. KGAA (DE) | 2023-09-07 | — | — | WO | disclosed |
| EP-4107325-A1 | TEXTILE TREATMENT COMPOSITION | Henkel AG & Co. KGaA (DE) | 2022-12-28 | — | — | EP | disclosed |
| WO-2000024721-A2 | FRAGRANCE PRO-ACCORDS AND ALDEHYDE AND KETONE FRAGRANCE LIBRARIES | THE PROCTER & GAMBLE COMPANY (US) | 2000-05-04 | — | — | WO | disclosed |
| WO-1999043639-A1 | TERTIARY ALCOHOL FRAGRANCE RAW MATERIAL DELIVERY SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-02 | — | — | WO | disclosed |
| EP-0918835-A1 | RINSE ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF FRAGRANCE PRECURSORS | THE PROCTER & GAMBLE COMPANY (US) | 1999-06-02 | — | — | EP | disclosed |
| WO-1999021954-A1 | LAUNDRY COMPOSITIONS HAVING REDUCED MALODOR AND METHODS FOR PROVIDING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 1999-05-06 | — | — | WO | disclosed |
| WO-1998006803-A1 | RINSE ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF FRAGRANCE PRECURSORS | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-19 | — | — | WO | disclosed |
| EP-0169581-B1 | ANTITUSSIVE AND MUCUS REGULATING 2-SUBSTITUTED THIAZOLIDINES | BOEHRINGER BIOCHEMIA ROBIN S.p.A. (IT) | 1989-12-06 | — | — | EP | disclosed |
| US-4857643-A | Antitussive and mucus regulating 2-substituted thiazolidines | BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) | 1989-08-15 | — | — | US | disclosed |
| US-4798898-A | BRONCHODILATORS | BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) | 1989-01-17 | — | — | US | disclosed |
| EP-0169581-A2 | Antitussive and mucus regulating 2-substituted thiazolidines | BOEHRINGER BIOCHEMIA ROBIN S.p.A. (IT) | 1986-01-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12527779-B2 | Prostaglandin E2 (PGE2) EP4 receptor antagonists | PTGER1, PTGER4, PTGER3 | NPSR1 670/4885CTSS 4092/4885CTSK 3922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.